Evidence map›Paper›PMID 33322484›Full record

ReviewInternational journal of molecular sciences2020

In Vivo Tracking of Extracellular Vesicles by Nuclear Imaging: Advances in Radiolabeling Strategies.

Sara Almeida, Liliana Santos, Amílcar Falcão, Célia Gomes, Antero Abrunhosa

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Journal of extracellular vesicles · 2025
    Article
  6. Exosome tracking by magnetic resonance imaging.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  7. Review
  8. Article
  9. In Vivo Evaluation ofPharmaceutics · 2024
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Molecular Imaging in Nanomedical Research.International journal of molecular sciences · 2022
    Article
  16. Nanomaterial Probes for Nuclear Imaging.Nanomaterials (Basel, Switzerland) · 2022
    Review
  17. Review
  18. Advances of engineered extracellular vesicles-based therapeutics strategy.Science and technology of advanced materials · 2022
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sara AlmeidaCIBIT/ICNAS-Institute for Nuclear Sciences Applied to Health, University of Coimbra, 3000-548 Coimbra, Portugal.
Liliana SantosCIBIT/ICNAS-Institute for Nuclear Sciences Applied to Health, University of Coimbra, 3000-548 Coimbra, Portugal.
Amílcar FalcãoCIBIT/ICNAS-Institute for Nuclear Sciences Applied to Health, University of Coimbra, 3000-548 Coimbra, Portugal.
Célia GomesiCBR-Coimbra Institute for Clinical and Biomedical Research, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
Antero AbrunhosaCIBIT/ICNAS-Institute for Nuclear Sciences Applied to Health, University of Coimbra, 3000-548 Coimbra, Portugal.ORCID 0000-0002-4145-854X

Funding

COMPETE-FEDER POCI-01-0145-FEDER-007440Liga Portuguesa contra o Cancro/Lions Portugal 2020PORTUGUESE SCIENCE AND TECHNOLOGY FOUNDATION (FCT) PD/BDE/142929/2018PORTUGUESE SCIENCE AND TECHNOLOGY FOUNDATION (FCT) PD/BDE/150707/2020PORTUGUESE SCIENCE AND TECHNOLOGY FOUNDATION (FCT) UID/NEU/04539/2019
6 · The paper itself

Abstract

Extracellular vesicles (EVs) are naturally secreted vesicles that have attracted a large amount of interest in nanomedicine in recent years due to their innate biocompatibility, high stability, low immunogenicity, and important role in cell-to-cell communication during pathological processes. Their versatile nature holds great potential to improve the treatment of several diseases through their use as imaging biomarkers, therapeutic agents, and drug-delivery vehicles. However, the clinical translation of EV-based approaches requires a better understanding of their in vivo behavior. Several imaging technologies have been used for the non-invasive in vivo tracking of EVs, with a particular emphasis on nuclear imaging due to its high sensitivity, unlimited penetration depth and accurate quantification. In this article, we will review the biological function and inherent characteristics of EVs and provide an overview of molecular imaging modalities used for their in vivo monitoring, with a special focus on nuclear imaging. The advantages of radionuclide-based imaging modalities make them a promising tool to validate the use of EVs in the clinical setting, as they have the potential to characterize in vivo the pharmacokinetics and biological behavior of the vesicles. Furthermore, we will discuss the current methods available for radiolabeling EVs, such as covalent binding, encapsulation or intraluminal labeling and membrane radiolabeling, reporting the advantages and drawbacks of each radiolabeling approach.

Indexed as

RadioisotopesAnimalsCell CommunicationDrug Delivery SystemsExtracellular VesiclesHumansNanomedicineRadioisotopesextracellular vesiclesin vivo trackingnuclear imagingradiolabeling

Identifiers

PMID33322484
PMCPMC7764519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.